OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein
Xiaoguang Li, Qian Ba, Yanling Liu, et al.
Cell Discovery (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 51
Xiaoguang Li, Qian Ba, Yanling Liu, et al.
Cell Discovery (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 51
Showing 1-25 of 51 citing articles:
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo, Chi Teng Vong, Hanbin Chen, et al.
Chinese Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 453
Hua Luo, Chi Teng Vong, Hanbin Chen, et al.
Chinese Medicine (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 453
New opportunities and challenges of natural products research: When target identification meets single-cell multiomics
Yuyu Zhu, Zijun Ouyang, Haojie Du, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4011-4039
Open Access | Times Cited: 247
Yuyu Zhu, Zijun Ouyang, Haojie Du, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4011-4039
Open Access | Times Cited: 247
Dihydroartemisinin: A Potential Natural Anticancer Drug
Xiaoshuo Dai, Xiaoyan Zhang, Wei Chen, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 2, pp. 603-622
Open Access | Times Cited: 163
Xiaoshuo Dai, Xiaoyan Zhang, Wei Chen, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 2, pp. 603-622
Open Access | Times Cited: 163
Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds
Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1141-1200
Closed Access | Times Cited: 118
Hui Li Ang, Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1141-1200
Closed Access | Times Cited: 118
New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114491-114491
Open Access | Times Cited: 71
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114491-114491
Open Access | Times Cited: 71
Engineered mitochondrial ROS scavenger nanocomplex to enhance lung biodistribution and reduce inflammation for the treatment of ARDS
Huoli Hu, Wenjia Zhang, Yundong Zhou, et al.
Advanced Composites and Hybrid Materials (2024) Vol. 7, Iss. 6
Closed Access | Times Cited: 20
Huoli Hu, Wenjia Zhang, Yundong Zhou, et al.
Advanced Composites and Hybrid Materials (2024) Vol. 7, Iss. 6
Closed Access | Times Cited: 20
Artemisinin, the Magic Drug Discovered from Traditional Chinese Medicine
Jigang Wang, Chengchao Xu, Yin Kwan Wong, et al.
Engineering (2018) Vol. 5, Iss. 1, pp. 32-39
Open Access | Times Cited: 157
Jigang Wang, Chengchao Xu, Yin Kwan Wong, et al.
Engineering (2018) Vol. 5, Iss. 1, pp. 32-39
Open Access | Times Cited: 157
Artemisinin and its derivatives: a promising cancer therapy
Bushra Hafeez Kiani, Waqas Khan Kayani, Asma Umer Khayam, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 8, pp. 6321-6336
Closed Access | Times Cited: 85
Bushra Hafeez Kiani, Waqas Khan Kayani, Asma Umer Khayam, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 8, pp. 6321-6336
Closed Access | Times Cited: 85
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope
Atif Zafar, Wei Wang, Gang Liu, et al.
Cancer Letters (2020) Vol. 496, pp. 16-29
Open Access | Times Cited: 82
Atif Zafar, Wei Wang, Gang Liu, et al.
Cancer Letters (2020) Vol. 496, pp. 16-29
Open Access | Times Cited: 82
Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review
Ka Hong Wong, Donglin Yang, Shanshan Chen, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 4, pp. 475-490
Open Access | Times Cited: 39
Ka Hong Wong, Donglin Yang, Shanshan Chen, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 4, pp. 475-490
Open Access | Times Cited: 39
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Roohi Mohi-ud-din, Apporva Chawla, Pooja Sharma, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 32
Roohi Mohi-ud-din, Apporva Chawla, Pooja Sharma, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 32
Monomeric Targeted Protein Degraders
Emily J. Hanan, Jun Liang, Xiaojing Wang, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 20, pp. 11330-11361
Closed Access | Times Cited: 57
Emily J. Hanan, Jun Liang, Xiaojing Wang, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 20, pp. 11330-11361
Closed Access | Times Cited: 57
Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
Lavinia Salama, Elizabeth Pastor, Tyler Stone, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 347-347
Open Access | Times Cited: 50
Lavinia Salama, Elizabeth Pastor, Tyler Stone, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 347-347
Open Access | Times Cited: 50
Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 31
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, et al.
Frontiers in Plant Science (2022) Vol. 13
Open Access | Times Cited: 31
Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
Ran Yu, Guihua Jin, Manabu Fujimoto
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 39
Ran Yu, Guihua Jin, Manabu Fujimoto
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 39
Recent pharmacological advances in the repurposing of artemisinin drugs
Yuqing Meng, Nan Ma, Haining Lyu, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 6, pp. 3156-3181
Closed Access | Times Cited: 37
Yuqing Meng, Nan Ma, Haining Lyu, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 6, pp. 3156-3181
Closed Access | Times Cited: 37
Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence
Shupei Wei, Lili Liu, Zhiyu Chen, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 1, pp. 276-284
Open Access | Times Cited: 36
Shupei Wei, Lili Liu, Zhiyu Chen, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 1, pp. 276-284
Open Access | Times Cited: 36
Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling
Yue Li, Xiaoyan Zhou, Jiali Liu, et al.
Life Sciences (2020) Vol. 248, pp. 117454-117454
Closed Access | Times Cited: 34
Yue Li, Xiaoyan Zhou, Jiali Liu, et al.
Life Sciences (2020) Vol. 248, pp. 117454-117454
Closed Access | Times Cited: 34
Artemisinin Inhibits the Migration and Invasion in Uveal Melanoma via Inhibition of the PI3K/AKT/mTOR Signaling Pathway
Mohd Farhan, Marta Silva, Xingan Xing, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 31
Mohd Farhan, Marta Silva, Xingan Xing, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 31
PDGFR dimer-specific activation, trafficking and downstream signaling dynamics
Madison A. Rogers, Maria B. Campaña, Robert C. Long, et al.
Journal of Cell Science (2022) Vol. 135, Iss. 17
Open Access | Times Cited: 19
Madison A. Rogers, Maria B. Campaña, Robert C. Long, et al.
Journal of Cell Science (2022) Vol. 135, Iss. 17
Open Access | Times Cited: 19
AXL promotes malignant phenotypes in tumor cells and might be a potential antitumor target of natural products
Yuan Yuan, Shan Wang, Jialei Fu, et al.
Advanced Chinese Medicine (2025)
Open Access
Yuan Yuan, Shan Wang, Jialei Fu, et al.
Advanced Chinese Medicine (2025)
Open Access
PDGFC secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and immunosuppression in lung adenocarcinoma
Meimei Cui, Xiaodi Ding, Yu Jiang, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Meimei Cui, Xiaodi Ding, Yu Jiang, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Exploring Combinations of Dihydroartemisinin for Cancer Therapy: A Comprehensive Review
K. Usha Rani, Rohan Chand Sahu, Aiswarya Chaudhuri, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 765, pp. 151854-151854
Closed Access
K. Usha Rani, Rohan Chand Sahu, Aiswarya Chaudhuri, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 765, pp. 151854-151854
Closed Access
Dihydroartemisinin Inhibits Oral Cancer Cell Migration, associated with Impairment of Cytoskeleton Organization and Cell Membrane Fluidity
P. Zheng, Shanwei Shi, Zheng Wang, et al.
Food Bioscience (2025), pp. 106648-106648
Closed Access
P. Zheng, Shanwei Shi, Zheng Wang, et al.
Food Bioscience (2025), pp. 106648-106648
Closed Access
Molecular targeted study in tumors: From western medicine to active ingredients of traditional Chinese medicine
Ruixiao Li, Qi Li, Qing Ji
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109624-109624
Open Access | Times Cited: 32
Ruixiao Li, Qi Li, Qing Ji
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109624-109624
Open Access | Times Cited: 32
